ArticleBlood cancer journal2025

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.

Valentin Letailleur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.